---
title: "Disc Medicine (IRON) Receives a Buy from LifeSci Capital"
type: "News"
locale: "zh-HK"
url: "https://longbridge.com/zh-HK/news/276517296.md"
description: "LifeSci Capital analyst Rami Katkhuda has maintained a Buy rating on Disc Medicine (NASDAQ: IRON) with a price target of $100.00. Katkhuda, a 5-star analyst, has an average return of 31.8% and a 55.75% success rate. Additionally, Truist Financial's Danielle Brill also issued a Buy rating on Disc Medicine on February 17, while TipRanks reiterated a Hold rating on February 4."
datetime: "2026-02-21T15:35:35.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/276517296.md)
  - [en](https://longbridge.com/en/news/276517296.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/276517296.md)
---

> 支持的語言: [简体中文](https://longbridge.com/zh-CN/news/276517296.md) | [English](https://longbridge.com/en/news/276517296.md)


# Disc Medicine (IRON) Receives a Buy from LifeSci Capital

LifeSci Capital analyst Rami Katkhuda maintained a Buy rating on Disc Medicine today and set a price target of $100.00.

### President's Day Sale - 70% Off

-   Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
-   Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential

According to TipRanks, Katkhuda is a 5-star analyst with an average return of 31.8% and a 55.75% success rate. Katkhuda covers the Healthcare sector, focusing on stocks such as Disc Medicine, Vera Therapeutics, and Viridian Therapeutics.

In addition to LifeSci Capital, Disc Medicine also received a Buy from Truist Financial’s Danielle Brill in a report issued on February 17. However, on February 4, TipRanks – OpenAI reiterated a Hold rating on Disc Medicine (NASDAQ: IRON).

### 相關股票

- [Disc Medicine (IRON.US)](https://longbridge.com/zh-HK/quote/IRON.US.md)

## 相關資訊與研究

- [Ironveld Advances Magnetite Restart but Warns on Funding and Going Concern Risk](https://longbridge.com/zh-HK/news/281150461.md)
- [IRON Investors Have Opportunity to Join Disc Medicine, Inc. Fraud Investigation with the Schall Law Firm](https://longbridge.com/zh-HK/news/279133165.md)
- [AITX Wraps Inaugural Global Sales Conference After ISC West](https://longbridge.com/zh-HK/news/281205719.md)
- [AITX Highlights Record ISC West 2026 Presence, Partnerships](https://longbridge.com/zh-HK/news/281002644.md)
- [Medi Assist Allots 92,415 ESOP Shares, Marginally Raises Equity Capital](https://longbridge.com/zh-HK/news/281606683.md)